Persistent identifier url
https://hdl.handle.net/1887/61931Documents
- 01 - Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
- version: Not Applicable (or Unknown)
- Full text at Publisher's site
-
Open Access
